Liver mass pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
Line 65: | Line 65: | ||
* Bile ductular proliferation | * Bile ductular proliferation | ||
* Cells of chronic inflammation | * Cells of chronic inflammation | ||
|- | |- | ||
|Hemangioma | |Hemangioma | ||
Line 108: | Line 101: | ||
|Lymphangioma | |Lymphangioma | ||
| | | | ||
* Lymphangioma is caused by either sequestration of | |||
** Lymph tissue | |||
** Abnormal budding of lymph vessels | |||
** Lack of fusion with the [[venous]] system, | |||
** Obstruction of lymph vessels. | |||
| | | | ||
**[[Trisomy 13]] | |||
**[[Tirsomy 18]] | |||
**[[Trisomy 21]] | |||
| | | | ||
*[[Turner syndrome]] | |||
*[[Noonan syndrome]] | |||
*[[Down syndrome]] | |||
| | | | ||
*Grey-white mass | |||
*Well circumscribed | |||
*Edematous appearance | |||
*Variable size (may be massive) | |||
*Filled with serous fluid | |||
*Smooth inner lining | |||
| | | | ||
*Thin walled channels lined by [[endothelium]] | |||
*Intraluminal accumulation of [[eosinophilic]] deposits | |||
*Clusters of intraluminal [[lymphocyte]]s | |||
*D2-40 +ve | |||
|- | |- | ||
|Angiomyolipoma | |Angiomyolipoma | ||
Line 161: | Line 168: | ||
| | | | ||
**Nodular or diffusely infiltrative. | **Nodular or diffusely infiltrative. | ||
**Pale in relation to surrounding liver or green. | **Pale in relation to surrounding liver or green. | ||
| | | | ||
Line 170: | Line 176: | ||
|Cholangiocarcinoma | |Cholangiocarcinoma | ||
| | | | ||
*The epithelial cell lining the bile ducts are called cholangiocytes. | |||
*The malignant transformsation of cholangiocytes leads to cholangiocarcinoma.<ref name="FavaLorenzini2012">{{cite journal|last1=Fava|first1=G.|last2=Lorenzini|first2=I.|title=Molecular Pathogenesis of Cholangiocarcinoma|journal=International Journal of Hepatology|volume=2012|year=2012|pages=1–7|issn=2090-3448|doi=10.1155/2012/630543}}</ref> | |||
*Malignant transformation of cholangiocytes into cholangiocarcinoma include following stages:<ref name="targeting">{{cite journal |author=Sirica A |title=Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy |journal=Hepatology |volume=41 |issue=1 |pages=5–15 |year=2005 |id=PMID 15690474}}</ref> | |||
*#Hyperplasia | |||
*#Metaplasia | |||
*#Dysplasia | |||
*#Frank carcinoma | |||
*Progression of malignancy is believed to be due to:<ref name="targeting" /><ref>{{cite journal |author=Holzinger F, Z'graggen K, Büchler M |title=Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma |journal=Ann Oncol |volume=10 Suppl 4 |issue= |pages=122-6 |year= |id=PMID 10436802}}</ref><ref>{{cite journal |author=Gores G |title=Cholangiocarcinoma: current concepts and insights |journal=Hepatology |volume=37 |issue=5 |pages=961-9 |year=2003 |id=PMID 12717374}}</ref> | |||
**Inflammation | |||
**Obstruction of bile ducts | |||
**Biliary intraepithelia neoplasia. | |||
| | | | ||
* ARID1A | |||
* BAP1 | |||
* BRAF | |||
* FGFR2 | |||
* IDH1 | |||
* IDH2 | |||
* KMT2C | |||
* KRAS | |||
* PBRM1 | |||
* PEG3 | |||
* PTPN3 | |||
* RNF43 | |||
* ROBO2 | |||
* SMAD4 | |||
* TERT | |||
* TP53 | |||
| | | | ||
| | | | ||
*'''Mass-forming''' | |||
**Nodular lesion or mass in the hepatic parenchyma | |||
**Gray to gray-white, firm and solid carcinoma | |||
*'''Periductal infiltrating''' | |||
**Spreading of the carcinoma along the portal tracts with stricture of the affected bile ducts | |||
**Dilatation of the peripheral bile ducts | |||
*'''Intraductal growth types''' | |||
**Polypoid or papillary tumor within the variably dilated bile duct lumen | |||
**Malignant progression of an intraductal papillary neoplasm of the bile duct | |||
| | | | ||
*Cuboidal or columnar mucin producing cells | |||
*Dense fibrous(desmoplastic) stroma. | |||
|- | |- | ||
|Hepatic abscess | |Hepatic abscess | ||
| | | | ||
* In patients the [[Reticuloendothelial system|reticuloendothelial cells]] ([[kupffer cells]]) of [[liver]] control the transient portal [[bacteremia]] | |||
* In elderly and [[immunocompromised]] the [[bacteria]] can overwhelm the [[kupffer cells]] and lead to an [[abscess]].<ref name="pmid1863218">{{cite journal| author=Stain SC, Yellin AE, Donovan AJ, Brien HW| title=Pyogenic liver abscess. Modern treatment. | journal=Arch Surg | year= 1991 | volume= 126 | issue= 8 | pages= 991-6 | pmid=1863218 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1863218 }}</ref> | |||
* Development of pyogenic liver abscess is the result of extension of infection from surrounding organs.<ref name="pmid17861705">{{cite journal| author=Munro JC| title=VII. Lymphatic and Hepatic Infections Secondary to Appendicitis. | journal=Ann Surg | year= 1905 | volume= 42 | issue= 5 | pages= 692-734 | pmid=17861705 | doi= | pmc=1425980 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17861705 }}</ref><ref name="pmid8651751">{{cite journal| author=Huang CJ, Pitt HA, Lipsett PA, Osterman FA, Lillemoe KD, Cameron JL et al.| title=Pyogenic hepatic abscess. Changing trends over 42 years. | journal=Ann Surg | year= 1996 | volume= 223 | issue= 5 | pages= 600-7; discussion 607-9 | pmid=8651751 | doi= | pmc=1235191 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8651751 }}</ref><ref name="pmid15578367">{{cite journal| author=Rahimian J, Wilson T, Oram V, Holzman RS| title=Pyogenic liver abscess: recent trends in etiology and mortality. | journal=Clin Infect Dis | year= 2004 | volume= 39 | issue= 11 | pages= 1654-9 | pmid=15578367 | doi=10.1086/425616 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15578367 }}</ref> | |||
| | | | ||
| | | | ||
| | | | ||
*Single or multiple cavities, filled with fowl smelling, creamy yellow [[Necrosis|necrotic]] material, usually in [[right lobe of liver]]. | |||
*The [[abscess]] may have [[fibrous capsule]] which is a centimeter or more thick and gradually merges into the [[Parenchyma|liver parenchyma]]. | |||
| | | | ||
*Multiple [[Neutrophil|neutrophilic]] [[abscesses]] with areas of [[necrosis]] are seen in the [[Parenchyma|liver parencyma]].<ref name="abscess">https://librepathology.org/wiki/Liver_pathology Accessed on February 22, 2017</ref><ref name="pmid11882760">{{cite journal| author=Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL et al.| title=Hepatic abscess in patients with chronic granulomatous disease. | journal=Ann Surg | year= 2002 | volume= 235 | issue= 3 | pages= 383-91 | pmid=11882760 | doi= | pmc=1422444 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11882760 }}</ref> | |||
*[[Suppuration]], [[liquefaction]] | |||
*Chronic [[Inflammation|inflammatory]] infiltrate consisting of [[lymphocytes]], [[Macrophages|epithelioid macrophages]], [[eosinophils]], and [[neutrophils]]. | |||
|- | |- | ||
|Parasitic cysts | |Parasitic cysts | ||
(Echinococcous) | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
*Cysts tend to be: | |||
**Filled with clear fluid | |||
**White appearance | |||
**Solitary | |||
**[[Unilocular hydatid disease|Unilocular]] | |||
| | | | ||
*Cyst wall composed of an acellular laminated external layer and a thin, germinal (nucleated) inner layer | |||
*Brood capsule with protoscoleces inside | |||
|} | |} | ||
Revision as of 03:17, 4 February 2018
Liver Mass Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Liver mass pathophysiology On the Web |
American Roentgen Ray Society Images of Liver mass pathophysiology |
Risk calculators and risk factors for Liver mass pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]
Overview
Pathophysiology
Genetics
Associated Conditions
Gross Pathology
Pathogeneis | Genetics | Associated conditions | Gross Pathology | Microscopic Pathology | |
---|---|---|---|---|---|
Hepatocellular adenoma |
|
|
|
|
|
Focal nodular hyperplasia |
|
|
|
|
|
Hemangioma |
|
|
|
| |
Hepatic Cyst |
|
|
| ||
Lymphangioma |
|
|
| ||
Angiomyolipoma |
|
|
| ||
HCC |
|
|
|
| |
Cholangiocarcinoma |
|
|
|
| |
Hepatic abscess |
|
|
| ||
Parasitic cysts
(Echinococcous) |
|
|
Microscopic Pathology
References
- ↑ Fava, G.; Lorenzini, I. (2012). "Molecular Pathogenesis of Cholangiocarcinoma". International Journal of Hepatology. 2012: 1–7. doi:10.1155/2012/630543. ISSN 2090-3448.
- ↑ 2.0 2.1 Sirica A (2005). "Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy". Hepatology. 41 (1): 5–15. PMID 15690474.
- ↑ Holzinger F, Z'graggen K, Büchler M. "Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma". Ann Oncol. 10 Suppl 4: 122–6. PMID 10436802.
- ↑ Gores G (2003). "Cholangiocarcinoma: current concepts and insights". Hepatology. 37 (5): 961–9. PMID 12717374.
- ↑ Stain SC, Yellin AE, Donovan AJ, Brien HW (1991). "Pyogenic liver abscess. Modern treatment". Arch Surg. 126 (8): 991–6. PMID 1863218.
- ↑ Munro JC (1905). "VII. Lymphatic and Hepatic Infections Secondary to Appendicitis". Ann Surg. 42 (5): 692–734. PMC 1425980. PMID 17861705.
- ↑ Huang CJ, Pitt HA, Lipsett PA, Osterman FA, Lillemoe KD, Cameron JL; et al. (1996). "Pyogenic hepatic abscess. Changing trends over 42 years". Ann Surg. 223 (5): 600–7, discussion 607-9. PMC 1235191. PMID 8651751.
- ↑ Rahimian J, Wilson T, Oram V, Holzman RS (2004). "Pyogenic liver abscess: recent trends in etiology and mortality". Clin Infect Dis. 39 (11): 1654–9. doi:10.1086/425616. PMID 15578367.
- ↑ https://librepathology.org/wiki/Liver_pathology Accessed on February 22, 2017
- ↑ Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL; et al. (2002). "Hepatic abscess in patients with chronic granulomatous disease". Ann Surg. 235 (3): 383–91. PMC 1422444. PMID 11882760.